Skip to Content

Join the 'Non-Small Cell Lung Cancer' group to help and get support from people like you.

Non-Small Cell Lung Cancer News

Related terms: Cancer, Lung, Non-Small Cell, Lung Cancer, Non-Small Cell, NSCLC

Global Recession May Have Contributed to Cancer Deaths

Posted 3 days ago by Drugs.com

THURSDAY, May 26, 2016 – The 2008 global economic crisis has been linked to a sharp rise in deaths from cancer, a new study reports. Unemployment and cuts in public health-care spending were associated with more than 260,000 additional cancer deaths by 2010. Most of those deaths – 160,000 – were in the European Union, the researchers said. The study included 70 countries and a total of more than 2 billion people, according to the report published online May 25 in The Lancet. "Cancer is a leading cause of death worldwide, so understanding how economic changes affect cancer survival is crucial," lead author Dr. Mahiben Maruthappu, of Imperial College London, said in a journal news release. "We found that increased unemployment was associated with increased cancer mortality, but that universal health coverage protected against these effects. This was especially the case for treatable ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Brain Tumor, Melanoma, Skin Cancer, Pancreatic Cancer, Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Melanoma - Metastatic, Stomach Cancer, Bladder Cancer, Gastric Cancer, Breast Cancer - Palliative, Testicular Cancer, Solid Tumors

Exercise May Cut Risk of 13 Cancers, Study Suggests

Posted 13 days ago by Drugs.com

MONDAY, May 16, 2016 – Exercise may significantly reduce your risk for many types of cancer, including some of the most lethal forms of the disease, a large review suggests. Working out for even a couple of hours a week appears to shrink the risk of breast, colon and lung cancer, said researchers who looked at 1.4 million adults. "Those are three of the four major cancers that affect Americans today," said Marilie Gammon. She is a professor of epidemiology with the University of North Carolina at Chapel Hill Gillings School of Public Health. And fitness buffs, take heart – your cancer risk appears to continue to decline as you rack up hours of physical activity, with no apparent upper plateau, said study lead author Steven Moore, an investigator with the U.S. National Cancer Institute. "The more activity, the more the benefit," Moore said. "As people did more, their risk continued to ... Read more

Related support groups: Cancer, Breast Cancer, Leukemia, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Multiple Myeloma, Endometrial Cancer, Small Cell Lung Cancer, Acute Myeloid Leukemia, Stomach Cancer, Bladder Cancer, Breast Cancer, Prevention, Acute Lymphoblastic Leukemia, Head and Neck Cancer, Gastric Cancer, Osteolytic Bone Lesions of Multiple Myeloma, Urinary Tract Cancer, Acute Myeloblastic Leukemia

Radon in the Home May Be Linked to Blood Cancers in Women

Posted 3 May 2016 by Drugs.com

TUESDAY, May 3, 2016 – New research suggests a strong link between exposure to high levels of radon in the home and women's risk of blood cancers. Radon is a naturally occurring radioactive gas, the U.S. Environmental Protection Agency says. It's known to cause lung cancer and is the second leading cause of lung cancer in the United States, the researchers said. The American Cancer Society collected information over 19 years on more than 140,000 Americans as part of a prevention study. During that time, just over 3,000 cases of blood cancer were diagnosed. The cancers included leukemia, lymphoma and myeloma, the study found. Women who lived in counties with the highest radon levels were 63 percent more likely to develop blood cancers than those in counties with the lowest radon levels. There was no link seen among men, the study noted. The study was published online recently in the ... Read more

Related support groups: Cancer, Leukemia, Lung Cancer, Lymphoma, Non-Small Cell Lung Cancer, Multiple Myeloma, Poisoning, Small Cell Lung Cancer, Toxic Reactions Incl Drug and Substance Abuse

Could Talk Therapy Ease Chemo-Related Memory Issues?

Posted 2 May 2016 by Drugs.com

MONDAY, May 2, 2016 – A type of psychotherapy might help cancer survivors deal with the long-term thinking problems some experience after chemotherapy, researchers say. It's estimated that about half of those who undergo chemotherapy for cancer develop what's often called "chemo brain." For instance, they may have trouble following conversations or remembering the steps in a project, according to background notes with the new study. Although usually mild, these changes can affect quality of life, job performance and relationships, said the researchers from the Eastern Maine Medical Center and Lafayette Family Cancer Center in Bangor, Maine. The researchers developed a cognitive-behavioral therapy (CBT) program called Memory and Attention Adaptation Training to help cancer survivors prevent or manage these memory problems. Their study involved 47 breast cancer survivors who underwent ... Read more

Related support groups: Cancer, Methotrexate, Breast Cancer, Prostate Cancer, Fluorouracil, Gleevec, Lung Cancer, Colorectal Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Brain Tumor, Breast Cancer, Metastatic, Melanoma, Xeloda, Tasigna, Pancreatic Cancer, Skin Cancer, Ovarian Cancer, Sprycel, Endometrial Cancer

'Palliative Care' Gets a Bad Rap, Study Finds

Posted 19 Apr 2016 by Drugs.com

TUESDAY, April 19, 2016 – The term "palliative care" triggers negative feelings among many cancer patients, and needs "rebranding," researchers say. The stigma surrounding palliative care can mean patients wait too long to receive supportive care that improves their quality of life, said researchers at the Princess Margaret Cancer Center in Toronto. This new study shows there's a "branding issue," said principal investigator Dr. Camilla Zimmermann, head of palliative care for the hospital and the University Health Network. Palliative care "is not something to be afraid of or that is stigmatizing, but is helpful even while patients are receiving life-prolonging therapies," Zimmermann said in a network news release. She and her colleagues analyzed interviews with 48 patients who had advanced cancer and an estimated survival of between six and 24 months. Half the patients received early ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Melanoma, Pancreatic Cancer, Skin Cancer, Ovarian Cancer, Cervical Cancer, Melanoma - Metastatic, Stomach Cancer, Breast Cancer, Prevention, Head and Neck Cancer, Gastric Cancer, Testicular Cancer, Breast Cancer - Palliative, Salivary Gland Cancer, Urinary Tract Cancer

Drug Seems to Extend Survival for Advanced Melanoma Patients

Posted 18 Apr 2016 by Drugs.com

MONDAY, April 18, 2016 – More than one-third of advanced melanoma patients were still alive five years after starting therapy with the cancer drug nivolumab (Opdivo), researchers are reporting. "In 2012, we saw some very promising early evidence that this drug could not only cause the regression of very advanced cancer in patients with melanoma, lung or kidney cancers that had not responded to other forms of therapy, but we also saw that these responses appeared to be very durable," said lead researcher Dr. Suzanne Topalian. She is a professor of surgery and oncology at Johns Hopkins University School of Medicine, in Baltimore. Opdivo was approved for the treatment of advanced melanoma by the U.S. Food and Drug Administration in 2014. The results of this follow-up study, funded by Bristol-Myers Squibb, which makes Opdivo, were to be presented Sunday at the American Association for ... Read more

Related support groups: Lung Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Melanoma, Small Cell Lung Cancer, Melanoma - Metastatic, Opdivo, Wilms' Tumor, Nivolumab

Black Smokers Less Likely to Get Lung Cancer Screening

Posted 19 Mar 2016 by Drugs.com

FRIDAY, March 18, 2016 – Differences in smoking habits between black and white Americans may lead to lower lung cancer screening rates for blacks, new research suggests. Researchers reviewed federal government data from 1965 to 2012. They found that blacks are less likely than whites to start smoking in their late teens, but also less likely to quit as they get older. The study also found that black smokers use fewer cigarettes a day than white smokers. These racial differences result in important and somewhat contradictory differences in lifetime cigarette exposure, the Yale School of Public Health team said. While blacks tend to continue smoking into their later years, the fact that they tend to smoke fewer cigarettes means that have fewer average "pack-years," calculated by multiplying the number of packs smoked per day by years of smoking, the researchers noted. "Pack-years" is one ... Read more

Related support groups: Smoking, Smoking Cessation, Lung Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Diagnosis and Investigation

FDA Expands Use of Xalkori (crizotinib) to Treat ROS-1 Positive Non-Small Cell Lung Cancer

Posted 11 Mar 2016 by Drugs.com

March 11, 2016 – The U.S. Food and Drug Administration today approved Xalkori (crizotinib) to treat people with advanced (metastatic) non-small cell lung cancer (NSCLC) whose tumors have an ROS-1 gene alteration. Xalkori is the first and only FDA approved treatment for patients with ROS-1 positive NSCLC. Lung cancer is the leading cause of cancer-related deaths in the United States, with an estimated 221,200 new diagnoses and 158,040 deaths in 2015, according to the National Cancer Institute. ROS-1 gene alterations, thought to lead to abnormal cells, have been identified in various cancers, including NSCLC. ROS-1 gene alterations are present in approximately 1 percent of patients with NSCLC. The overall patient and disease characteristics of NSCLC with ROS-1 gene alterations appear similar to NSCLC with anaplastic lymphoma kinase (ALK) gene alterations, for which crizotinib use was ... Read more

Related support groups: Lung Cancer, Non-Small Cell Lung Cancer, Xalkori, Crizotinib

Can Certain 'Poor Carb' Diets Raise Nonsmokers' Lung Cancer Risk?

Posted 4 Mar 2016 by Drugs.com

FRIDAY, March 4, 2016 – Even people who've never smoked can get lung cancer, and a new study suggests their risk for the disease may rise if they eat a diet rich in certain carbohydrates. These so-called "high glycemic index" diets – regimens that trigger higher levels of insulin in the blood – tend to be heavy in refined, "poor quality" carbs, one expert explained. "The glycemic index and glycemic load are methods to estimate the quality and quantity of dietary carbohydrates," said Dr. Rishi Jain, a medical oncologist at Fox Chase Cancer Center in Philadelphia. "Examples of foods with a high glycemic index include white bread and white potatoes." Jain explained that as rates of obesity and heart risk factors rise in the United States, so does the number of Americans with "insulin resistance," a precursor to diabetes. And he said insulin-linked disorders, which are often tied to ... Read more

Related support groups: Smoking, Smoking Cessation, Dietary Supplementation, Lung Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer

Lung Cancer Survivors May Be Getting Too Many PET Scans

Posted 23 Feb 2016 by Drugs.com

MONDAY, Feb. 22, 2016 – Many lung and esophageal cancer survivors have PET imaging scans as part of ongoing monitoring for the possible return of cancer, but a new study suggests that many of those scans may be unnecessary. In addition, the researchers found that having the pricey scans as the first line of imaging detection might not improve survival rates. PET scans can detect early signs of cancer. But these tests can be expensive and aren't recommended by experts as the first option for long-term monitoring of cancer survivors. Medicare limits follow-up PET scans for cancer survivors to three per patient, the study authors noted. "PET scanning is a great technology and very effective, but using it [to screen for cancer recurrence] doesn't seem to make any difference for these cancers that have a relatively poor prognosis," said study author Dr. Mark Healy, a surgical resident and ... Read more

Related support groups: Lung Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Body Imaging

Could a Lung Cancer Drug Work Better With Coke?

Posted 13 Feb 2016 by Drugs.com

FRIDAY, Feb. 12, 2016 – Patients with the leading form of lung cancer may be able to look to Coca-Cola Classic to solve a common medicinal challenge, new research suggests. As the Dutch scientists explain it, the effectiveness of the powerful lung cancer drug Tarceva (erlotinib) depends on the pH level of the stomach. But many people on Tarceva must also take a proton pump inhibitor heartburn medication – such as Nexium or Prilosec – which raises stomach pH to more alkaline levels. That higher pH can lower the absorption rate for Tarceva, cutting its effectiveness in fighting non-small-cell lung cancer, research suggests. One prior study involving healthy volunteers found the use of Prilosec lowered blood concentrations of Tarceva by 61 percent. What to do? In the new study, researchers led by Dr. Roelof van Leeuwen, of Erasmus MC Cancer Institute in Rotterdam, the Netherlands, ... Read more

Related support groups: Omeprazole, Nexium, Prilosec, Protonix, Pantoprazole, Non-Small Cell Lung Cancer, Tarceva, Tasigna, Sprycel, Esomeprazole, Prilosec OTC, Iressa, Dasatinib, Nilotinib, Erlotinib, Gefitinib, Protonix IV, Nexium 24HR, Nexium IV, Omesec

Weight May Influence Outcomes After Lung Cancer Surgery

Posted 26 Jan 2016 by Drugs.com

TUESDAY, Jan. 26, 2016 – Lung cancer surgery patients are most likely to have complications and to die if they're either too thin or fat, a new study suggests. The study included more than 41,000 people who had lung cancer surgery between 2009 and 2014. Patients were categorized according to their body mass index (BMI) – an estimate of body fat based on weight and height. While the study couldn't prove cause-and-effect, people who were either underweight or severely obese had the highest rates of complications and death following surgery, according to the study. The findings were to be presented Tuesday at the annual meeting of the Society of Thoracic Surgeons in Phoenix. Weight "is associated with a patient's overall physiology and health, but overweight people need to have more muscle to carry the extra weight around," study co-leader Dr. Trevor Williams of the University of ... Read more

Related support groups: Surgery, Obesity, Lung Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Vascular Surgery, Bronchogenic Carcinoma

Smokers With Pneumonia at Risk for Lung Cancer: Study

Posted 14 Jan 2016 by Drugs.com

THURSDAY, Jan. 14, 2016 – Smokers diagnosed with pneumonia may be at greater risk for developing lung cancer, a new study suggests. Researchers found that 9 percent of smokers admitted to the hospital for pneumonia developed lung cancer within one year, so they recommend early screening for the disease among heavy smokers treated for pneumonia. "Lung cancer is truly aggressive. The only chance of recuperation is if it's caught before it begins to cause any symptoms at all. The idea is to find the tumor well in advance," said study leader Dr. Daniel Shepshelovich, from Tel Aviv University's Sackler Faculty of Medicine and the Rabin Medical Center, in Israel. "Previous studies have shown that a low-dose radiation CT scan conducted once a year on heavy smokers has the potential to lower lung cancer mortality rates," he said in a university news release. "But this requires huge resources, ... Read more

Related support groups: Smoking, Pneumonia, Smoking Cessation, Nicotine, Lung Cancer, Non-Small Cell Lung Cancer, Nicorette, Nicoderm CQ, Nicotrol Inhaler, Small Cell Lung Cancer, Commit, Habitrol, Streptococcal Pneumonia, Nicotrol NS, Nicotrol TD, Nicorelief, Nicorette DS, ProStep, Bronchogenic Carcinoma

Teikoku Pharma USA, Inc. Announces FDA Approval of Docetaxel Injection, Non-Alcohol Formula

Posted 30 Dec 2015 by Drugs.com

San Jose, Calif. - December 28, 2015 - Teikoku Pharma USA (TPU) announced today that the U.S. Food and Drug Administration ("FDA") has approved Docetaxel Injection, Non-Alcohol Formula ("Docetaxel Injection") for the treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, and head and neck cancer. Teikoku entered into an exclusive licensing agreement with Eagle Pharmaceuticals Inc. ("Eagle Pharmaceuticals") in October 2015 to market, sell and distribute Docetaxel Injection in the U.S. The main difference, compared to other docetaxel formulations, is that Docetaxel Injection is the first non-alcohol formulation approved in the U.S. Further differentiating it from some of the currently marketed docetaxel formulations is that Teikoku's Docetaxel Injection: Requires no prior dilution with a diluent and is ready to add to the infusion solution; and ... Read more

Related support groups: Breast Cancer, Prostate Cancer, Non-Small Cell Lung Cancer, Head and Neck Cancer, Gastric Cancer, Docetaxel

Keytruda May Help Fight Tough-to-Treat Lung Cancer

Posted 21 Dec 2015 by Drugs.com

SATURDAY, Dec. 19, 2015 – The immune therapy drug Keytruda (pembrolizumab) may extend the lives of people with advanced lung cancer, a new study finds. Keytruda is commonly used to treat other tumor types, and made headlines recently after it helped former President Jimmy Carter fight off brain cancer. In this study, researchers compared Keytruda to the chemotherapy drug docetaxel in more than 1,000 patients with non-small cell lung cancer. All of the patients were battling tumors that had progressed even after chemotherapy. Non-small cell lung cancer is the leading form of the disease. All of the patients' tumors produced a protein called PD-L1, which can shield the tumor from immune system attack, according to a team led by Dr. Roy Herbst, professor of medicine at Yale University School of Medicine. Among patients with the highest amounts of PD-L1, those who received Keytruda lived ... Read more

Related support groups: Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Taxotere, Keytruda, Docetaxel, Docefrez

Page 1 2 3 4 5 6 7 8 9 Next

Ask a Question

Further Information

Related Condition Support Groups

Lung Cancer

Related Drug Support Groups

methotrexate, Avastin, Tarceva, Taxol, Xalkori, cisplatin, Taxotere, cyclophosphamide, paclitaxel, view more... Gemzar, capecitabine, Iressa, gemcitabine, Opdivo, Alimta, erlotinib, Keytruda, bevacizumab, Cyramza, gefitinib, Abraxane, docetaxel, amifostine, Gilotrif, Platinol, crizotinib, afatinib, Navelbine, ramucirumab, Methotrexate LPF Sodium, pembrolizumab, vinorelbine, pemetrexed, Alecensa, cetuximab, Trexall, Tagrisso, nivolumab, alectinib, osimertinib, Zykadia, Portrazza, Ethyol, ceritinib, porfimer, paclitaxel protein-bound, necitumumab, Onxol, Platinol-AQ, Folex PFS, Photofrin, Docefrez